IU School of Medicine researchers discover new treatment with help from Tyler Trent’s cell lines

Most Indiana residents recognize the name Tyler Trent. Tyler was a Purdue University student and football superfan who died on January 1, 2019, after waging a long and valiant fight against an aggressive form of bone cancer. Tyler’s legacy as a research advocate started years ago while he was a patient at Riley Children’s Health. He donated several tumor samples to cancer researchers at IU School of Medicine and nationally advocated that others do the same.

Now, researchers at Indiana University School of Medicine have found a combination therapy that significantly slows tumor growth in models, built from cells taken from Tyler’s tumors. Learn more about this amazing discovery and what it means for future treatment of pediatric sarcomas, including osteosarcoma, on the Indiana University School of Medicine website.